ScreenerHero

CERO CERo Therapeutics Holdings, Inc.

NAS · US · Healthcare · Biotechnology · cero.bio
0.0110USD-4.35%Mkt Cap: 787940 $P/E: 0.00

CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap787.94K USD
Enterprise Value17.03M USD
Revenue (TTM)—
Gross Profit-605.42K USD
Net Income (TTM)-19.92M USD
Revenue/Share—
Last Price0.0110 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.95
EV/Revenue—
P/S—
P/B-0.02
EPS (TTM)39.28
EPS (Forward)-3.26
52W Range
0.00750% of range6.700
52W High6.700 USD
52W Low0.0075 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE365.75%
ROA-547.09%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.08M USD
CapEx (TTM)—
FCF Margin—
FCF Yield508.34%
Net Debt15.08M USD
Net Debt/EBITDA-0.85
Balance Sheet
Debt/Equity-0.13
Current Ratio0.05
Quick Ratio0.03
Book Value/Sh-0.50 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.63M
Float69.62M
Insiders2.95%
Institutions0.09%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short0
Short (prev mo.)72.18K
Technical
SMA 500.0108 (+1.5%)
SMA 2000.0278 (-60.4%)
Beta0.22
S&P 52W Chg16.45%
Avg Vol (30d)365.76K
Avg Vol (10d)429.75K
Technical Indicators
RSI (14)49.4
MACD0.0001
MACD Signal0.0001
MACD Hist.+0.0000
BB Upper0.0140 USD
BB Middle0.0111 USD
BB Lower0.0081 USD
BB Width53.43%
ATR (14)0.0021 USD
Vol Ratio (20d)0.75x